Mindray présente ses solutions hospitalières intelligentes à Arab Health 2023

DUBAÏ, Émirats arabes unis30 janvier 2023 /PRNewswire/ — Mindray (« l’entreprise »), l’un des principaux fournisseurs mondiaux de dispositifs médicaux et de solutions médicales, participe à l’un des salons les plus importants et les plus respectés du domaine médical, Arab Health 2023 du 30 janvier au 2 février. L’entreprise a présenté ses solutions médicales et sa technologie révolutionnaire à plus de 50 000 visiteurs au Dubai World Trade Centre.

« En tant que partenaire de confiance pour la fourniture de solutions complètes pour les établissements de santé, Mindray repousse les limites de l’innovation pour contribuer à un écosystème médical intelligent. Cette année, nous sommes ravis de présenter nos solutions hospitalières intelligentes à un public mondial. Avec des innovations plus avancées s’adaptant au domaine médical, nous renforcerons les systèmes de santé locaux au Moyen-Orient et en Afrique », a déclaré Kewen Xu, directeur général de Mindray RDM.

L’hôpital intelligent de Mindray vise à créer un écosystème médical où les dispositifs médicaux sont intégrés dans des scénarios cliniques. Ce système relie l’ensemble des parcours préhospitaliers, intrahospitaliers et interhospitaliers des patients et permet aux appareils d’appoint de se connecter et de fonctionner de façon fluide, de faire circuler les données entre les différents services et hôpitaux, et d’améliorer l’efficacité du travail des cliniciens.

Parmi la gamme complète de produits Mindray, des solutions pour les services des urgences, les blocs opératoires, les USI, la RRAC, des solutions d’imagerie médicale et d’orthopédie sont présentées sur le stand ; la solution informatique M-Connect et la solution informatique d’imagerie médicale MiCo+ ont attiré beaucoup d’attention. À l’aide d’une interface standard, la solution informatique M-Connect permet de surveiller le patient tout en optimisant le flux de travail et en améliorant l’efficacité. Toutes les données peuvent être affichées, analysées, associées à des alarmes et communiquées à un système tiers pour obtenir un aperçu plus complet de l’état de santé du patient. De même, la solution informatique d’imagerie médicale MiCo+ relie plusieurs modalités et établissements médicaux, permettant un diagnostic à distance et une consultation en ligne pour fournir un meilleur service d’imagerie médicale.

Le système portable de surveillance des patients mWear, le système de perfusion BeneFusion i/u, le défibrillateur BeneHeart D30/D60 et la lampe chirurgicale série HyLED C ont tous été dévoilés lors du salon de cette année en tant que nouveautés du catalogue de l’entreprise pour la surveillance des patients et la réanimation. De plus, Mindray introduit un certain nombre de systèmes d’imagerie médicale tels que l’échographe portable sans fil TE Air, l’échographe diagnostique de la série TEX 20 et l’échographe diagnostique de la gamme Consona N9.

Les visiteurs du salon peuvent également observer comment les défibrillateurs automatiques externes (DEA) de la série BeneHeart C de Mindray sont déployés dans divers établissements d’une ville et manipulés via le système de gestion à distance des DEA de l’entreprise, qui peut suivre l’état de chaque DEA en temps réel, notamment leur emplacement et leur niveau de batterie, et qui simplifie la gestion de l’ensemble de la flotte d’appareils. Il fait partie des solutions d’urgence préhospitalières et permet d’encourager les initiatives pour la santé cardiaque, telles que l’initiative Dubai Heart Safe City menée par la ville hôte pour promouvoir la santé cardiaque.

Les visiteurs sont invités à s’arrêter au stand Mindray au #S1 A10 pendant la durée du salon pour voir ces solutions médicales et bien d’autres. Après Arab Health 2023, Mindray participera également au Medlab Middle East les 6 et 9 février, où elle présentera ses solutions holistiques en diagnostic in vitro.

Photo – https://mma.prnewswire.com/media/1991861/IMG_9255.jpg

Mindray Demonstrates Its Smart Hospital Solutions at Arab Health 2023

DUBAI, UAE, Jan. 30, 2023 /PRNewswire/ — Mindray (“the company”), a leading global provider of medical devices and solutions, is attending one of the largest and most respected exhibitions in the medical field, the Arab Health 2023 from Jan. 30 to Feb. 2. The company has exhibited its medical solutions and groundbreaking technology to over 50,000 visitors at the Dubai World Trade Centre.

“As a trusted partner in providing comprehensive solutions for healthcare facilities, Mindray is pushing the boundaries of innovation to contribute to an intelligent medical ecosystem. This year, we’re delighted to present our smart hospital solutions to global audience. With more advanced innovations adapting to the medical field, we will better empower local healthcare systems in the Middle East and Africa region,” said Kewen Xu, General Manager of Mindray ROW region.

Mindray’s Smart Hospital aims to create a medical ecosystem where medical devices are integrated into clinical scenarios. This system links the entire pre-hospital, intra-hospital, and inter-hospital journeys of patients and allows beside devices to connect and perform seamlessly, achieving data sharing between departments and hospitals, and enabling clinicians to work together more effectively.

Among Mindray’s comprehensive product portfolio from ER, OR, ICU, ERAS, Medical Imaging solutions to Orthopedics solutions at the booth, the M-Connect IT solution and MiCo+ Medical Imaging IT solution attract much attention. Utilizing a standard interface, the M-Connect IT solution provides patient-centric monitoring to optimize clinical workflow and improve efficiency. All data can be displayed, analyzed, alarmed and reported to a third-party system for a more comprehensive picture of patient health. Likewise, MiCo+ medical imaging IT Solution connects multiple modalities and medical institutions, allowing for remote diagnosis and online consultation to provide better medical imaging service.

The mWear Wearable Patient Monitor, the BeneFusion i/u Infusion System, the BeneHeart D30/D60 Defibrillator, and the HyLED C series Surgical Light were all unveiled at this year’s expo as new additions to the company’s products for patient monitoring and life support. Additionally, Mindray is introducing a number of medical imaging systems such as the TE Air Wireless Handheld Ultrasound System, TEX 20 Series Diagnostic Ultrasound System, and Consona N9 Diagnostic Ultrasound System.

Expo visitors can also see how Mindray’s BeneHeart C Series automatic external defibrillators (AEDs) are deployed in various establishments throughout a city and managed through the company’s Remote AED Management system, which can track each AED’s status in real-time, including its location and battery level, and simplifies management of the entire fleet of devices. As a part of the pre-hospital emergency solution, it empowers heart health initiatives such as the host city’s Dubai Heart Safe City, aiding in the promotion of cardiac health.

Visitors are encouraged to stop by the Mindray booth at #S1 A10 during the expo to see these and other medical solutions. Following Arab Health 2023, Mindray will also participate at Medlab Middle East on Feb. 6-9, where they will be presenting their holistic solutions in In-Vitro Diagnostics.

Photo – https://mma.prnewswire.com/media/1991861/IMG_9255.jpg

WHO calls for more action to end ‘cycles of poverty and stigma’ related to tropical diseases

More countries have worked to eliminate dengue, leprosy and other neglected tropical diseases (NTDs) over the past decade, but greater efforts and investment are needed in the face of pandemic-related disruptions, the World Health Organization (WHO) said on Monday.

To mark World Neglected Tropical Diseases Day, the UN agency has released a report highlighting progress and challenges in delivering care for these 20 conditions, which mainly affect the world’s poorest people.

NTDs are caused by a variety of pathogens including viruses, bacteria, parasites, fungi and toxins, and can be deadly.  Other examples are Buruli ulcer, Chagas disease, chikungunya, rabies, scabies and yaws.

Stigma and hardship

They are mainly prevalent in tropical areas, primarily in locations where water safety, sanitation and access to healthcare are inadequate. These diseases often cause life-long stigma, and resulting economic hardship, and have devastating health, social and economic consequences.

Although nearly 180 countries and territories reported at least one case of NTDs in 2021, just 16 nations account for 80 per cent of the global burden. Globally, some 1.65 million people are estimated to require treatment for at least one of these diseases.

“Around the world, millions of people have been liberated from the burden of neglected tropical diseases, which keep people trapped in cycles of poverty and stigma,” said Tedros Adhanom Ghebreyesus, the WHO Director-General.

“But as this progress report shows, we still have a lot of work to do,” he added.

Building on progress

The report showed that the number of people requiring NTD interventions fell by 80 million between 2020 and 2021.

Furthermore, eight countries had eliminated at least one of these diseases during this period.  As of last year, the number stood at 47 countries, and more were on the road to achieving this target.

These accomplishments build on a decade of significant progress, said WHO, with 25 per cent fewer people requiring interventions in 2021 than in 2010.

Additionally, more than a billion people were treated for NTDs each year between 2016 and 2019.

The COVID-19 impact

However, the COVID-19 pandemic has also had significant impact on community-based interventions, access to health facilities, and on supply chains for healthcare products.

As a result, 34 per cent fewer people received treatment between 2019 and 2020, even if a general resumption of activities sparked an 11 per cent increase in recovery the following year, with roughly 900 million people treated.

In 2020, WHO’s governing body, the World Health Assembly, endorsed an NTD road map for the coming decade, and the report emphasizes the need for more action and investment to reverse delays and accelerate progress.

Accountability, financing and partnerships

Promoting country ownership and accountability, as well as sustainable and predictable financing, will be key to providing quality NTD services.

WHO also stressed the importance of multi-sectoral collaboration and partnerships.

Last week, the UN agency signed a new agreement with Gilead Sciences, a research-based American biopharmaceutical company, for the donation of 304,700 vials of AmBisome, an antifungal medicine used to treat visceral leishmaniasis in countries most impacted by the disease, such as Bangladesh, Ethiopia, India, Kenya, Nepal, Somalia and South Sudan.

This new three-year collaboration, which extends a previous agreement to 2025, is estimated at $11.3 million and also will support improved coverage and access to diagnosis and treatment.

WHO urged more partners and donors to fill existing gaps that hamper the full-scale implementation of NTD activities at the global and local levels.

 

Source: United Nations

Defense Minister receives his Djiboutian counterpart

Defense Minister of the Federal Government, Abdulkadir Mohamed Nur on Monday received his Djiboutian counterpart, Hassan Omar Mohamed at Aden Adde International Airport in Mogadishu.

Mohamed said that his visit aimed at participating a meeting on countering Al-Shabaab militants by leaders from troop contributing countries which will happen here in Mogadishu in the days ahead.

” We came here to attend ATMIS conference on counter terrorism and how we can be united against fighting Al-Shabaab. Djiabouti stands side by side with Somali brothers and sisters”, Mr. Mohamed said.

Ssomalia’s Defense Minister thanked Djibout’s role in the war on Al-Shabaab terrorists.

 

Source: Somalia National News Agency

JETEX LONDON WELCOMES THE WORLD

Jetex London welcomes the world as the brand’s newest FBO is now fully operational.

Dubai, United Arab Emirates, Jan. 30, 2023 (GLOBE NEWSWIRE) — Located at Hangar 510 at Biggin Hill Airport (EGKB/BQH), Jetex London has commenced full commercial operations and is welcoming international private jet flyers to the United Kingdom capital.

London Biggin Hill is a private airport which caters exclusively for aircraft in business and private aviation. 2022 was the strongest year ever for the airport, with more than 26,000 movements (up from 18,900 in 2021). It is recognized as a global center of excellence and the second private jet operation in the U.K. with 23% of London’s market share after Farnborough (31%) and ahead of Luton (22%). The airport typically connects flights to more than 750 destinations across over 70 countries.

Jetex London is conveniently located just nine miles from Canary Wharf and 15 miles from Central London, with helicopter transfers taking passengers to and from the heart of the British capital in just six minutes, with limousine transfers taking less than 50 minutes.

The modern airport runway (1,806 meters) allows most aircraft to operate without payload or range restrictions, including non-stop transatlantic flights.

“We are pleased with our arrival in London. Jetex already has a strong presence in Europe with a flagship private jet terminal at Paris Le Bourget, and the new flagship Jetex London is a natural evolution of our operations. Private flyers will enjoy a seamless travel experience complemented by the greatest levels of luxury hospitality, while employing the latest technology will allow us to minimize carbon footprint.”

Adel Mardini
Founder & CEO, Jetex

 Jetex London will offer a suite of flagship services for passengers and crews traveling through the airport. It is a seamless, intuitive and dedicated route for Jetex customers to begin or end their journey in supreme comfort. The on-site U.K. Border Force and customs control will ensure that passengers and crew enjoy an efficient ground experience, while Jetex will also offer assistance with ground transport, hotel accommodation, catering, concierge services and much more.

Biggin Hill’s green agenda is key to the airport’s future development, and it echoes the global sustainability commitment of Jetex. The airport has been offering sustainable aviation fuel (SAF) since April 2021.

 “We are extremely proud that Jetex has chosen London Biggin Hill Airport as the destination for its latest FBO – the first in the United Kingdom. Jetex is one of the most respected and acclaimed businesses in private aviation, with an ambitious growth roadmap that reflects our own. We stand at the ready to welcome Jetex’s customers to the capital and offer them the very best standards of service they have come to expect.”

Robert Walters
Commercial Director, London Biggin Hill Airport

With natural materials, soft lighting, and floor-to-ceiling windows, Jetex London is designed to feel like a warm, contemporary space. The 1,900 sq.m. private terminal will include several supremely comfortable lounges of understated luxury designed with passenger privacy in mind, retail and entertainment areas, fully equipped boardrooms, shower suites and much more. Crews will appreciate a full range of on-site recreational and flight support facilities.

Jetex London marks the company’s first entry into the U.K. as it looks forward to growing its operations in the market.

About Jetex:
An award-winning global leader in executive aviation, Jetex is recognized for delivering flexible, best-in-class trip support solutions to customers worldwide. Jetex provides exceptional private terminals (FBOs), aircraft fueling, ground handling and global trip planning. The company caters to both owners and operators of business jets for corporate, commercial and personal air travel. To find out more about Jetex, visit www.jetex.com and follow us on Instagram, Twitter, Facebook, and LinkedIn.

Attachment

Oleg Kafarov - Director of Portfolio Development & Corporate Communications
Jetex
+971 4 212 4900
teamorange@jetex.com

GlobeNewswire Distribution ID 8738614